Gentherm(THRM) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Gentherm reported record revenue of $1.5 billion for 2025, an increase of 2.9% compared to the prior year, or 1.8% when excluding foreign currency translation [12] - Adjusted EBITDA for 2025 was $175 million, representing 11% of sales, down from 12.6% the previous year due to higher material costs and expenses related to footprint realignment [13] - Operating cash flow increased by 7% to $117 million, despite building inventory throughout the year [13][14] Business Line Data and Key Metrics Changes - Automotive climate and comfort solutions revenue increased by 5.8% excluding foreign exchange effects, while other automotive products saw a decline of $28 million due to planned exits [12] - The company generated a commercial funnel totaling over $300 million in lifetime revenue from markets outside of light vehicles, including commercial vehicles and home and office applications [7][8] Market Data and Key Metrics Changes - Fourth quarter climate and comfort solutions revenue outgrew light vehicle production by 820 basis points, indicating strong global performance across product categories [13] - In China, Gentherm experienced strong growth, particularly with global OEMs, and finished the year with 60% of awards from domestic manufacturers [49] Company Strategy and Development Direction - Gentherm is focusing on scaling its core technologies beyond automotive applications, with a strategic combination with Modine Performance Technologies expected to close by the end of the year [6][19] - The merger is projected to create a $2.6 billion market leader with a goal to grow to over $3.5 billion by 2030, emphasizing operational excellence and market diversification [6][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth trajectory, expecting mid-single-digit growth above market levels in 2026, despite a slight decline in light vehicle production [15] - The company anticipates Adjusted EBITDA margins to improve to approximately 12% in 2026, with expectations for revenue growth driven by new program launches and adjacent market contributions [16][17] Other Important Information - Gentherm's FDA 510(k) submission for the Thermafix system is expected to generate revenue later this year, contributing to the medical segment's growth [9] - The company is prioritizing product lifecycle management and leveraging existing automotive intellectual property to enhance innovation in the medical market [8] Q&A Session Summary Question: Adjacent end markets and revenue expectations - Management confirmed they will continue to pursue adjacent markets, expecting home and office to contribute $50 million to $100 million in revenue by 2028, and anticipate significant contributions from medical products [31][32] Question: Footprint realignment timing and EBITDA expectations for 2027 - Management stated that the footprint transitions remain on track for completion in 2026, with benefits expected to flow through in 2027, leading to a potential step function change in margins [34][35] Question: China market positioning and production turbulence - Management reported strong growth in China, particularly with global OEMs, and emphasized a focus on rebalancing the mix towards domestic OEMs [48][49] Question: Thermafix system and future product launches - Management indicated that revenue from the Thermafix system is expected to start this year, and additional product launches leveraging existing technology are anticipated [52] Question: Opportunities in data centers for valves - Management highlighted potential applications in liquid cooling for data centers, facilitated by the merger with Modine Performance Technologies [53]